SeaStar Net Income From Continuing Ops from 2010 to 2026
| ICU Stock | USD 2.45 0.01 0.41% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -22.3 M | Current Value -23.5 M | Quarterly Volatility 9.7 M |
Check SeaStar Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SeaStar Medical's main balance sheet or income statement drivers, such as Tax Provision of 1.9 K, Depreciation And Amortization of 21.5 M or Interest Expense of 208.6 K, as well as many indicators such as Price To Sales Ratio of 43.04, Dividend Yield of 0.0 or Days Sales Outstanding of 242. SeaStar financial statements analysis is a perfect complement when working with SeaStar Medical Valuation or Volatility modules.
SeaStar | Net Income From Continuing Ops | Build AI portfolio with SeaStar Stock |
The evolution of Net Income From Continuing Ops for SeaStar Medical Holding provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how SeaStar Medical compares to historical norms and industry peers.
Latest SeaStar Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of SeaStar Medical Holding over the last few years. It is SeaStar Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SeaStar Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
SeaStar Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (9,442,256) | |
| Coefficient Of Variation | (102.81) | |
| Mean Deviation | 8,550,008 | |
| Median | (3,276,000) | |
| Standard Deviation | 9,707,377 | |
| Sample Variance | 94.2T | |
| Range | 23M | |
| R-Value | (0.79) | |
| Mean Square Error | 37.3T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | (1,524,549) | |
| Total Sum of Squares | 1507.7T |
SeaStar Net Income From Continuing Ops History
About SeaStar Medical Financial Statements
SeaStar Medical shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although SeaStar Medical investors may analyze each financial statement separately, they are all interrelated. The changes in SeaStar Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on SeaStar Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -22.3 M | -23.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SeaStar Stock Analysis
When running SeaStar Medical's price analysis, check to measure SeaStar Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SeaStar Medical is operating at the current time. Most of SeaStar Medical's value examination focuses on studying past and present price action to predict the probability of SeaStar Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SeaStar Medical's price. Additionally, you may evaluate how the addition of SeaStar Medical to your portfolios can decrease your overall portfolio volatility.